Many studies have confirmed that laboratory markers, such as anti-MDA5 antibody, KL-6, ferritin, LDH, CK, CRP, and NLR, may serve as diagnostic and/or prognostic biomarkers of disease activity in IIM-ILD (47–53). This evidence concerns the gene MUC1 and acquired idiopathic inflammatory myopathy.